메뉴 건너뛰기




Volumn 10, Issue 1, 2008, Pages 1-2

Transplant infectious disease: A moving target

(2)  Rubin, R H a   Hirsch, H H a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHEMOKINE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT;

EID: 38649104423     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2008.00297.x     Document Type: Editorial
Times cited : (11)

References (10)
  • 1
    • 33645694582 scopus 로고    scopus 로고
    • Immunosuppression: Evolution in practice and trends, 1994-2004
    • Meier-Kriesche HU, Li S, Gruessner RW, et al. Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant 2006 6 : 1111 1131.
    • (2006) Am J Transplant , vol.6 , pp. 1111-1131
    • Meier-Kriesche, H.U.1    Li, S.2    Gruessner, R.W.3
  • 3
    • 0001864473 scopus 로고    scopus 로고
    • Infection in the organ transplant recipient. Chapter 17
    • In: Rubin, R.H., Young, L.S., eds. (4th edn). New York: Kluwer Academic/Plenum Publishers
    • Rubin RH. Infection in the organ transplant recipient. Chapter 17. In : Rubin RH, Young LS, eds. Clinical Approach to Infection in the Compromised Host (4th edn). New York : Kluwer Academic/Plenum Publishers, 2002 : 573 680.
    • (2002) Clinical Approach to Infection in the Compromised Host , pp. 573-680
    • Rubin, R.H.1
  • 4
    • 0033551348 scopus 로고    scopus 로고
    • Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International valacyclovir cytomegalovirus prophylaxis transplantation study group
    • Lowance D, Neumayer HH, Legendre CM, et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International valacyclovir cytomegalovirus prophylaxis transplantation study group. N Engl J Med 1999 340 : 1462 1470.
    • (1999) N Engl J Med , vol.340 , pp. 1462-1470
    • Lowance, D.1    Neumayer, H.H.2    Legendre, C.M.3
  • 5
    • 0033188569 scopus 로고    scopus 로고
    • Mechanisms of human cytomegalovirus (hcmv) (re)activation and its impact on organ transplant patients
    • Reinke P, Prosch S, Kern F, Volk HD. Mechanisms of human cytomegalovirus (hcmv) (re)activation and its impact on organ transplant patients. Transpl Infect Dis 1999 1 : 157 164.
    • (1999) Transpl Infect Dis , vol.1 , pp. 157-164
    • Reinke, P.1    Prosch, S.2    Kern, F.3    Volk, H.D.4
  • 6
    • 84862859311 scopus 로고    scopus 로고
    • Cytomegalovirus and polyomavirus BK posttransplant
    • Egli A, Bodaghi S, Dumoulin A, et al. Cytomegalovirus and polyomavirus BK posttransplant. Nephrol Dial Transplant 2007 22 : 72 82.
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 72-82
    • Egli, A.1    Bodaghi, S.2    Dumoulin, A.3
  • 7
    • 34548735403 scopus 로고    scopus 로고
    • Evolving clinical strategies for transplantation in the HIV-positive recipient
    • Stock PG, Roland ME. Evolving clinical strategies for transplantation in the HIV-positive recipient. Transplantation 2007 84 : 563 571.
    • (2007) Transplantation , vol.84 , pp. 563-571
    • Stock, P.G.1    Roland, M.E.2
  • 8
    • 11844256985 scopus 로고    scopus 로고
    • Prevention of infection in adult travelers after solid organ transplantation
    • Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant 2005 5 : 8 14.
    • (2005) Am J Transplant , vol.5 , pp. 8-14
    • Kotton, C.N.1    Ryan, E.T.2    Fishman, J.A.3
  • 9
    • 38649126250 scopus 로고    scopus 로고
    • http://www.intmedpress.com/tid/
  • 10
    • 38649128537 scopus 로고    scopus 로고
    • http://www.blackwell-synergy.com/loi/tid


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.